Therapeutic drug monitoring of infliximab in spondyloarthritis. In addition to these retrospective studies, there is now also some prospective data assessing therapeutic drug monitoring. Conclusion infliximab and adalimumab showed similar drug survival as first and secondline antitumour necrosis factor treatments. Promonitor and qinflixi had the best agreement, making those assays fully interchangeable. Presently there is no standardised guidance defining a treatment strategy. Proactive therapeutic drug monitoring of infliximab. Infliximab ifx therapeutic drug monitoring tdm allows for objective decision making in patients with inflammatory bowel disease ibd and loss of response. It is the commercialized ceregistered version of ku leuvens homebrew assay, who is leading the way in therapeutic drug monitoring tdm. Jan 31, 2020 secondary failure to treatment was the most frequent reason for withdrawal. The purpose is to develop an individualised treatment strategy based on therapeutic drug monitoring tdm in order to optimise efficacy of infliximab inx. Increasing evidence supports the use of reactive therapeutic drug monitoring tdm in crohns disease cd and ulcerative colitis uc foll. However, the recommended target concentrations depend.
Therapeutic drug monitoring of adalimumab in patients with. Therapeutic drug monitoring of tumour necrosis factor inhibitors in the management of chronic inflammatory diseases. Expert committee on biological standardization geneva, 17. Putting tdm knowledge into practice frontline gastroenterology. The evidence supporting the use of therapeutic drug monitoring tdm based clinical algorithms for infliximab ifx and their role in clinical practice will be discussed. The commercialization of ctp, an infliximab ifx biosimilar, has the potential. The purpose is to develop an individualised treatment strategy based on therapeutic drug monitoring tdm in order to optimise efficacy of infliximab inx treatment. Therapeutic drug monitoring in inflammatory bowel disease ncbi. What are the evidencebased guidelines regarding the use of therapeutic drug. Therapeutic drug monitoring of infliximab compared to standard clinical treatment with infliximab.
Jul 14, 20 the evidence supporting the use of therapeutic drug monitoring tdm based clinical algorithms for infliximab ifx and their role in clinical practice will be discussed. Therapeutic drug monitoring tdm of mabs has the potential to guide to more effective. Background therapeutic drug monitoring tdm by measuring infliximab ifx trough levels and antibodies to infliximab ati is used to optimise treatment in inflammatory bowel disease. Jul 17, 2019 however, although the systematic use of therapeutic drug monitoring could potentially be beneficial and economically acceptable to drug dose optimization, it is not justifiable for all drugs.
Pdf therapeutic drug monitoring of infliximab compared to. What is the clinical effectiveness of therapeutic drug monitoring guided dosing of biologic medications for patients with inflammatory bowel disease. Infliximab is a humanized monoclonal antibody igg 1. Tnf therapies in patients with ibd depends upon target ranges. Therapeutic drug monitoring tdm of the most commonly used antitnf biologic medicines, infliximab and adalimumab, has emerged as a helpful tool for optimising the use and effectiveness of these. Methods this is a retrospective observational study. Reliability evaluation of four different assays for. Therapeutic drug monitoring of biologics in psoriasis. Comparison of drug survival between infliximab and adalimumab. However, although the systematic use of therapeutic drug monitoring could potentially be beneficial and economically acceptable to drug dose optimization, it is not justifiable for all drugs. Individual adjustment of infliximab dosage may help to improve the therapeutic response in spa. Therapeutic drug monitoring of tumour necrosis factor. Therapeutic drug monitoring of antitnf drugs prof ann gils laboratory for therapeutic and diagnostic antibodies department of pharmaceutical and pharmacological sciences, ku leuven.
Therapeutic drug monitoring, infliximab, immunogenicity, serum drug levels, personalised medicine background infliximab inx and other tumor necrosis factor inhibitors tnfi have. Jentzer a1, berger ae1, labetoulle r1, haccourt a1. In the presence of antiinfliximab antibodies, the infliximab drug level typically reflects the antibodyunbound fraction of infliximab concentration in serum. Using proactive therapeutic drug monitoring of antitumor. Therapeutic drug monitoring tdm of infliximab ifx concentration and antiinfliximab antibody ada titer informs physician clinical decisionmaking in the management of inflammatory bowel disease. Adalimumabinfliximab therapeutic drug monitoring ibd clinic. Drug levelhigh, 10mcgml drug levellow adalimumabinfliximab therapeutic drug monitoring none yes confirmdisease drug. Therapeutic drug monitoring, infliximab, immunogenicity, serum drug levels, personalised medicine background infliximab inx and other tumor necrosis factor inhibitors tnfi have revolutionised the treatment of a range of prevalent chronic immune mediated inflammatory diseases and remission has become an achievable treatment goal. Aga on therapeutic drug monitoring tdm in inflammatory bowel disease ibd. In many cases, tdm is crucial for the success of the treatment as the bioavailability is relevant for a drug to work. Laboratoriumaspecten van autoimmuniteit, vakb, 6 februari 20 leuven therapeutic drug monitoring of antitnf drugs prof ann gils laboratory for therapeutic and diagnostic antibodies. Introduction and aims infliximab ifx is a recognised effective therapy in moderate to severe inflammatory bowel disease ibd.
Biologic therapies, including the antitumor necrosis factor antitnf agents infliximab, adalimumab. Summary of abstracts therapeutic drug monitoring for patients with inflammatory bowel disease 4 table 1. Therapeutic drug monitoring is used for treatment as well as for diagnostic purposes. Targeted therapies have greatly improved the treatment of patients inflammatory joint diseases, but a significant proportion of patients either do not respond sufficiently to therapy or loose efficacy over. Therapeutic drug monitoring of monoclonal antibodies in. Guideline therapeutic drug monitoring in inflammatory. Therapeutic drug monitoring tdm of infliximab ifx appears to be beneficial for patients with inflammatory bowel disease ibd. Evaluation of infliximab and antiinfliximab lisatracker immunoassays for the therapeutic drug monitoring of sb2 infliximab biosimilar. Drug monitoring of infliximab biosimilars clinical diagnostics. Therefore, it is proposed to the ecbs that the candidate standard, coded 16170 be established as. Its main focus is on drugs with a narrow therapeutic window. Protocols ibd patients on biologic maintenance regime.
Therapeutic drug monitoring tdm is seen as one of the cornerstones of personalised medicine which has been widely used to improve the treatment of various diseases. It is easier to correlate the relationship between the drugs therapeutic or adverse effect on its. While infliximab has most commonly been measured by immunometric approaches, mass spectrometric approaches offer the opportunity to improve test accuracy and reduce test costs. Or adalimumab or antitumour necrosis factor figure s1. Pwe058 outcomes of using therapeutic drug monitoring to. Pdf reliability evaluation of four different assays for. In the recently published guidelines regarding the role of therapeutic drug monitoring tdm in inflammatory bowel disease ibd, the american gastroenterological association aga advocates reactive tdm in adults with active ibd failing response to antitumor necrosis factor tnf therapy. Therapeutic drug monitoring of biosimilars of infliximab can be. Available evidence indicates that a therapeutic drug monitoring strategy leads to major cost savings related to the anti. Drug levels vary due to individual pharmacokinetics. Therapeutic drug monitoring tdmguided antitnf dosing has emerged as a strategy to optimise treatment and maximise benefits from these drugs. Still, many patients do not respond sufficiently to therapy or lose efficacy over time.
This document presents the official recommendations of the american gastroenterological association aga on therapeutic drug monitoring tdm in inflammatory bowel. Therapeutic drug monitoring was associated with higher drug survival for both first and secondline antitumour necrosis factor treatments. Jul 05, 2019 therapeutic drug monitoring tdm is the clinical practice of measuring serum drug andor anti drug antibody ada concentrations to guide clinical decision making. This document presents the official recommendations of the american gastroenterological association aga on therapeutic drug monitoring tdm in inflammatory bowel disease ibd. Guideline therapeutic drug monitoring in inflammatory bowel. Therapeutic drug monitoring tdm, an individualised treatment strategy based on systematic assessments of serum drug concentrations, has. Infliximab inx and other tumour necrosis factor inhibitors tnfi have revolutionised the treatment of several immune. Infliximab inx and other tumour necrosis factor inhibitors tnfi have revolutionised the treatment of several immune mediated inflammatory diseases. In cases of nonresponse primary or secondary tdm can provide a clearer understanding of the cause of treatment failure and offer a rationale for steps taken to recapture response. Therapeutic drug monitoring in inflammatory bowel disease joseph d. Infliximab ifx is a chimeric monoclonal immunoglobulin g1 targeting tumour necrosis factor.
Tdm for antitnf agents involves measurement of drug levels and anti drug antibodies. Infliximab is a chimeric monoclonal antibody that binds to human tumor necrosis factor alpha and which is approved for refractory spondyloarthritis spa. Therapeutic drug monitoring tdm that guides infliximab. The majority of clinical experience in therapeutic drug monitoring stems from ifx. American gastroenterological association institute guideline.
Inflammatory bowel disease ibd crohns disease drugs. Therapeutic drug monitoring tdm is a branch of clinical chemistry and clinical pharmacology that specializes in the measurement of medication concentrations in blood. Therapeutic drug monitoring tdm of the most commonly used antitnf biologic medicines, infliximab and adalimumab, has emerged as a helpful tool for optimising the use and effectiveness of these drugs and can identify selected patients in whom it may be possible to reduce or even. Therapeutic monitoring of tnfalpha inhibitors could also potentially benefit people whose rheumatoid arthritis has a sustained response to these drugs and who could be considered for dose reduction. Our data further add to the importance of therapeutic drug monitoring of ifx in inflammatory bowel disease.
Therapeutic drug monitoring tdm of in fliximab for inflammatory bowel disease ibd is being increasingly proposed, particularly for. Mar 12, 2015 relevance of therapeutic drug monitoring. An automated mass spectrometric blood test for therapeutic. Therapeutic drug monitoring tdm is the clinical practice of measuring serum drug andor antidrug antibody ada concentrations to guide clinical decision making. The utility of infliximab therapeutic drug monitoring. Direct url citations appear in the printed text and are provided in the html and pdf. Jan 14, 2015 ridascreen ifx monitoring is an enzyme linked immunoassay intended for the quantitative determination of infliximab ifx, antitnf. Treating patients based on a treattotrough approach has been shown to be a costeffective strategy for inflammatory bowel disease ibd patients who have become unresponsive. Evaluation of infliximab and antiinfliximab lisatracker. Therapeutic monitoring of tnfalpha inhibitors in rheumatoid. Therapeutic drug monitoring tdm is a means by which drug concentrations in a patients blood can be monitored. Summary of abstracts therapeutic drug monitoring for patients with inflammatory bowel disease 3 research questions 1.
The 1ctld model may help to optimize the dosing regimen of infliximab in routine therapeutic drug monitoring. Therapeutic drug monitoring to guide infliximab dose adjustment is. Therapeutic drug monitoring of infliximab compared to standard. Therapeutic monitoring of tnfalpha inhibitors could also potentially. Therapeutic drug monitoring of infliximab compared to. Drug levelhigh, 10mcgml drug levellow adalimumabinfliximab therapeutic drug monitoring none yes confirmdisease drug levellow 10mcgml switch inout of class treatas appropriatefor ibs drug level 310mcg. Impact of therapeutic drug level monitoring on outcomes of.
The large interindividual variation in serum drug concentrations on standard doses and the development of anti drug antibodies are thought to be major. Scottish biologic therapeutic drug monitoring service. Tu1818 ultraproactive therapeutic drug monitoring incorporating infliximab pointofcare testing with ad hoc dose adjustment reduces creactive protein levels in patients with ibd during infliximab maintenance treatment. Modelbased therapeutic drug monitoring of infliximab using a. Monitoring of drug levels and antidrug antibodies for tnf. Therapeutic drug monitoring in inflammatory bowel disease. Ytter, siddharth singh, on behalf of aga clinical guidelines committee 1division of gastroenterology and center for inflammatory bowel disease, beth israel deaconess. How, when, and for whom should we perform therapeutic drug. Therapeutic drug monitoring tdm can optimize the efficacy of infliximab ifx in patients with inflammatory bowel disease ibd. The introduction of infliximab therapeutic drug level. Jun 27, 2019 in conclusion, our study suggests that proactive tdm is associated with significant therapeutic benefits, including higher rates of mucosal healing and less surgery. Reliability evaluation of four different assays for therapeutic drug monitoring of infliximab levels article pdf available in therapeutic advances in gastroenterology 11.
Guide to gastroenterology biological therapeutic drug. Evaluation of infliximab and antiinfliximab lisatracker immunoassays for the therapeutic drug monitoring of sb2 infliximab. Proactive infliximab drug monitoring is superior to. Introduction the use of therapeutic drug monitoring tdm for infliximab and adalimumab in the treatment of inflammatory bowel disease ibd is becoming increasingly commonplace. American gastroenterological association institute. Practical use of infliximab concentration monitoring. Ecco guidelines suggest therapeutic drug monitoring tdm can help determine whether infliximab ifx should be continued or doseadjusted during maintenance treatment of inflammatory. Dec, 2017 accurate individual concentration predictions can be obtained using a single infliximab concentration measurement and information regarding only the last infusion. The american gastroenterological association suggests reactive therapeutic drug monitoring to guide treatment changes in adult patients treated with infliximab for active inflammatory bowel disease feuerstein 2017. Therapeutic drug monitoring of infliximab for the management of. Vande casteele and colleagues recently published an abstract examining the impact of prospective, longterm followup and therapeutic drug level monitoring. Therapeutic drug monitoring of infliximab clinical diagnostics. A retrospective analysis of a realworld experience. Because of the delay between blood samples taken at trough and availability of results, dose adjustments can only be carried out at the next infusion, typically 8 weeks later.
The guideline was developed by the agas clinical guidelines committee and approved by the aga governing board. Therapeutic drug monitoring tdm, defined as the assessment of drug concentrations and antibodies, is an important tool toward optimizing biological therapy. Therapeutic drug monitoring of infliximab in spondyloarthrit. We aimed to explore the clinical outcomes of tdm for patients with crohns disease on ifx in real life setting. In these circumstances, therapeutic drug monitoring of infliximab offers a rational approach to clinical decision making and is associated with improved outcomes. All four assays seem suitable for therapeutic drug monitoring of infliximab. New steps in infliximab therapeutic drug monitoring in. Studies evaluating optimal cutoff trough values of the various biologics in terms of clinical efficacy are also invaluable. Background and aims therapeutic drug monitoring tdm is an effective strategy in the management of inflammatory bowel disease ibd patients and is widely. Therapeutic drug monitoring may be helpful with respect to patient compliance, individual pharmacodynamics and clinical response. However, a further study may be required to facilitate harmonization in clinical practice.
The utility of infliximab therapeutic drug monitoring among. The interest of therapeutic drug monitoring of infliximab. Still, many patients do not respond sufficiently to. Dried blood samples can support monitoring of infliximab. Therapeutic drug monitoring importance, guidelines.
297 39 67 1346 1418 1331 990 675 1498 527 850 741 809 469 1483 1440 317 680 312 966 462 795 1526 1345 1307 1060 1213 1160 866 430 269 1441 1480 46 578